Guardian Financial Partners LLC Invests $216,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Guardian Financial Partners LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 420 shares of the healthcare conglomerate’s stock, valued at approximately $216,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Advocacy Wealth Management Services LLC boosted its position in shares of UnitedHealth Group by 75.8% during the first quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 25 shares during the period. Cascade Investment Advisors Inc. boosted its position in shares of UnitedHealth Group by 100.0% during the first quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after buying an additional 30 shares during the period. Evolution Advisers Inc. purchased a new position in shares of UnitedHealth Group during the first quarter valued at approximately $38,000. Rise Advisors LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $38,000. Finally, Cordant Inc. purchased a new position in shares of UnitedHealth Group during the first quarter valued at approximately $45,000. Hedge funds and other institutional investors own 87.25% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $517.46 on Friday. The firm has a market capitalization of $484.02 billion, a PE ratio of 27.02, a price-to-earnings-growth ratio of 1.61 and a beta of 0.76. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.77. UnitedHealth Group Incorporated has a 1-year low of $383.12 and a 1-year high of $553.29. The company’s fifty day moving average price is $530.11 and its 200-day moving average price is $512.45.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, beating analysts’ consensus estimates of $5.24 by $0.33. UnitedHealth Group had a net margin of 5.95% and a return on equity of 25.45%. The firm had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. During the same period in the previous year, the company earned $4.70 earnings per share. The business’s quarterly revenue was up 12.6% compared to the same quarter last year. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 21.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Monday, September 12th were issued a $1.65 dividend. This represents a $6.60 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend was Friday, September 9th. UnitedHealth Group’s payout ratio is 34.46%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 465 shares of the company’s stock in a transaction on Friday, August 26th. The shares were sold at an average price of $542.37, for a total value of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares of the company’s stock, valued at $18,866,882.82. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other news, CEO Andrew Witty sold 11,376 shares of the stock in a transaction dated Monday, July 18th. The shares were sold at an average price of $527.90, for a total transaction of $6,005,390.40. Following the sale, the chief executive officer now directly owns 76,559 shares of the company’s stock, valued at approximately $40,415,496.10. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CAO Thomas E. Roos sold 465 shares of the stock in a transaction dated Friday, August 26th. The stock was sold at an average price of $542.37, for a total transaction of $252,202.05. Following the sale, the chief accounting officer now directly owns 34,786 shares in the company, valued at $18,866,882.82. The disclosure for this sale can be found here. Over the last three months, insiders have sold 139,051 shares of company stock valued at $74,450,958. 0.40% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on UNH shares. Raymond James lifted their price target on shares of UnitedHealth Group from $620.00 to $635.00 in a research note on Thursday. Deutsche Bank Aktiengesellschaft lifted their price target on shares of UnitedHealth Group from $556.00 to $569.00 and gave the company a “buy” rating in a research note on Thursday, September 8th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $570.00 to $587.00 in a research note on Monday, July 18th. SVB Leerink lifted their price target on shares of UnitedHealth Group from $600.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, July 18th. Finally, Credit Suisse Group boosted their price objective on shares of UnitedHealth Group from $575.00 to $579.00 and gave the stock an “outperform” rating in a research note on Monday, July 18th. Three research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $586.40.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.